COA - Chromophobe and Oncocytic Tumor Alliance
@kidneycoa
Followers
97
Following
158
Statuses
140
RT @LauraEsfeller: Please join me in supporting @kidneycoa #GivingTuesday campaign, raising funds for a #chromophobeRCC Scholar in Training…
0
2
0
RT @KidneyCancer: LAST DAY to apply for an AACR Scholars in Training Award: We are excited to collaborate with @AA…
0
5
0
0
2
4
RT @kidneycoa: We are excited to announce our collaboration with @AACR to support early-career researchers. Together, we are committed to t…
0
5
0
RT @KidneyCancer: Last day to get @AACR membership, a requirement in order to apply for the Scholar-In-Training Awards! We're proud to su…
0
3
0
RT @kidneycan: We are excited to announce our collaboration with @AACR to support early-career researchers. Together, we are committed to t…
0
3
0
RT @KidneyCancer: Learn more about #ChRCC Focus Awardee @Dr_Liz_Ellis_MD who works to identify biomarkers to assess if #chromophobe tumors…
0
6
0
RT @KidneyCancer: We are excited to collaborate with @AACR and fellow advocacy orgs to support early-career #kidneycancer researchers! ✍️…
0
2
0
We are excited to announce our collaboration with @AACR to support early-career researchers. Together, we are committed to the future of #kidneycancer research. Apply Now to the Scholars in Training Award— don’t miss this opportunity: #AACRScholars
1
5
7
Continuing our series of introductions to the passionate team behind the COA (Chromophobe and Oncocytic Tumor Alliance) board, this week we're excited to spotlight one of our founding board members, @LauraEsfeller
0
1
2
Congrats to @Dr_Liz_Ellis_MD, the recipient of our first co-funded grant with @KidneyCancer for #Chromophobe RCC! We are excited to see where this research leads.
@LauraBukavinaMD @ClevelandClinic 🎉Congratulations @Dr_Liz_Ellis_MD @MDAndersonNews! She received KCA’s #ChRCC Focus Award in partnership with @kidneycoa to identify biomarkers that might indicate if #chromophobeRCC will respond to treatment.
0
2
9
RT @KidneyCancer: We're excited to see how these exceptional researchers continue to advance #kidneycancer and bring hope to patients and f…
0
2
0
Continuing our series of introductions to the passionate team behind the COA board, this week we're excited to spotlight our newest board member, Lindsay Walker! #chromophobe #chrcc
0
1
3
Over the next few weeks, we're excited to introduce you to the dedicated individuals on the COA (Chromophobe and Oncocytic Tumor Alliance) board, starting with our founder and president, Katie Coleman. Click here to learn more about Katie: #chromophobe
1
4
13
RT @KidneyCancer: Teri Wight was diagnosed with #chRCC in 2014. In a guest blog post, Teri described things she wished she knew, including:…
0
3
0
Molecular Characterization of Metastatic Oncocytoma With Exceptional Response to Treatment: A Case Report
2
3
15
RT @FabioSchutz78: Dr. @LisaHenske from @DanaFarber_GU discussed the highly unmet need of treatments and potential targets (ferroptoses and…
0
5
0
RT @KidneyCancer: Such a pleasure running into friends @ASCO #ASCO24! Thanks for visiting, @kaydaustin! We’re proud to partner with both @k…
0
5
0
Looking forward to seeing continued analysis as the dataset grows to include additional centers and patients. Major kudos on the multi-center analysis, we love to see this kind of collaboration 👏 @OncHahn @MVossMD @NazliDizman @PavlosMsaouel
0
1
2